Asia

India-Nepal collaboration to launch joint PhD programme in medical technology

To work jointly to promote faculty exchanges, joint research programmes, and international internships...

Mirxes receives US FDA’s breakthrough device designation for blood-based cancer detection test

GASTROClear is the first miRNA blood test and the first gastric cancer molecular test globally to receive FDA Breakthrough Device Designation...

ABVC BioPharma to open new facility in Taiwan for manufacturing retinal surgery device

A joint effort between ABVC's Taiwan affiliate and co-development partner, BioFirst Corporation...

Malaysian startup SayHeart launches AI-driven medical imaging for dentists

Announces AI-powered visual-to-text transformation pilot testing for dental X-rays, with Kindlehouse Dentistry partnership...

Yashoda Medicity and Draeger India Collaborate for South Asia's Largest Modular ICU Setup and Advanced Medical Gas System

Yashoda Medicity, the upcoming healthcare facility by Yashoda Foundations in Indirapuram, is collaborating with Draeger India, a renowned global medical and safety technology solutions provider. Yashoda Medicity is the new addition to the renowned healthcare institution Yashoda Super Speciality Hospital, well acknowledged for its exceptional patient care and facilities. Together, Yashoda Medicity and Dräger are embarking on a groundbreaking initiative to establish one of the largest modular Int...

“Asia-Pacific represents a vast and relatively untapped market for Digital Pathology”

JelloX Biotech, a Taiwanese startup, is at the forefront of revolutionising cancer pathology by utilising 3D digital imaging and Artificial Intelligence (AI) technology. Its 3D imaging technology demonstrates potential beyond the field of oncology. In a groundbreaking paper published in February 2023, Dr Lin-Shien Fu and colleagues from Taiwan's Taichung Veterans General Hospital showcased the innovative application of their 3D pathology in analysing kidney inflammation caused by lupus nephritis...

Taiwan BioMed Industry Eyes $32B

Biomedicine is a top priority for Taiwan, with the government aiming to position the country as the leading hub for biomedical research and development in the Asia-Pacific region. By 2025, Taiwan aims to create 20 new medicines, introduce 80 high-value medical devices to the market, and elevate the biomedicine industry into a trillion-NT-dollar (approximately $32 billion) sector. The government has taken various initiatives, established biomedicines clusters and tweaked policies to achieve this ...

Rise of Healthcare Wearables

The wearable healthcare market in India is rapidly growing due to the increasing awareness of health and fitness among the Indian population, the prevalence of chronic diseases and the government's support for the adoption of wearables. Of course, there are a few challenges that need to be addressed, such as the lack of regulatory guidelines for wearables, the high cost of some devices and the lack of awareness about the benefits of wearables among the general public. Let's explore further the f...

Malaysia's healthcare player RSDH deploys AI tools in partnership with Annalise.ai & Amazon

The AI deployment will be the first-of-its-kind cloud installation by AWS in Malaysian hospitals...

HelpMeSee & USAID Partner to Train Cataract Specialists for India's Blind

HelpMeSee has announced a new partnership with the United States Agency for International Development (USAID) American Schools and Hospitals Abroad (ASHA) Initiative to train 100 new cataract specialists to help restore sight to India's cataract blind. Through this agreement, ASHA has provided funding to deploy two HelpMeSee eye surgery simulators to facilitate training at the HelpMeSee Mumbai Centre of Excellence for Simulation-Based Training. ...